Profile data is unavailable for this security.
About the company
Shanghai Haixin Group Co., Ltd. is a China based company principally engaged in the production and sales of textile products and pharmaceuticals. The Company operates its business through two segments. The Textile segment is mainly engaged in the production and sales of plush fabric and clothing. The Pharmaceutical segment is mainly engaged in the manufacture and sales of pharmaceutical products. In addition, The Company is also engaged in financial investment business and industrial plant rental management business. The Company operates its business in the domestic market and overseas markets.
- Revenue in CNY (TTM)1.11bn
- Net income in CNY171.70m
- Incorporated1993
- Employees760.00
- LocationShanghai Haixin Group Co LtdNo.688 Changxing RoadDongjing Town, Songjiang DistrictSHANGHAI 200001ChinaCHN
- Phone+86 2 163917000
- Fax+86 2 163917678
- Websitehttp://www.haixin.com.cn
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Yabao Pharmaceutical Group Co Ltd | 2.88bn | 204.43m | 4.36bn | 4.14k | 22.01 | 1.50 | -- | 1.51 | 0.2754 | 0.2754 | 3.81 | 4.05 | 0.7193 | 2.98 | 6.79 | 695,432.10 | 4.52 | 2.82 | 5.90 | 3.97 | 56.00 | 59.20 | 6.29 | 4.19 | 1.62 | 47.13 | 0.0675 | 43.74 | 7.05 | -0.0572 | 90.71 | -6.10 | 7.98 | -9.71 |
| Hangzhou Alltest Biotech Co Ltd | 718.48m | 184.83m | 4.36bn | 1.09k | 23.64 | 1.11 | -- | 6.07 | 2.33 | 2.33 | 9.02 | 49.43 | 0.165 | 2.13 | 6.17 | 657,349.00 | 4.24 | 23.35 | 4.57 | 26.83 | 46.83 | 58.34 | 25.69 | 39.07 | 10.16 | -- | 0.0056 | 29.79 | -77.73 | 32.59 | -84.75 | 26.19 | 72.77 | -- |
| Shanghai Haoyuan Chemexpress Co Ltd | 1.97bn | 97.97m | 4.37bn | 3.37k | 44.61 | 1.72 | -- | 2.22 | 0.652 | 0.652 | 13.10 | 16.92 | 0.4845 | 1.01 | 3.91 | 583,547.80 | 2.38 | 7.38 | 3.23 | 9.60 | 42.51 | 47.03 | 4.92 | 13.53 | 0.894 | 3.37 | 0.3013 | 14.37 | 38.44 | 44.33 | -34.18 | 47.24 | 48.95 | -- |
| Getein Biotech Inc | 1.31bn | 244.26m | 4.40bn | 2.14k | 18.00 | 1.66 | -- | 3.37 | 0.4816 | 0.4816 | 2.58 | 5.22 | 0.3502 | 1.61 | 2.77 | 611,337.70 | 6.63 | 13.25 | 9.24 | 18.45 | 66.13 | 65.57 | 18.92 | 28.13 | 1.97 | -- | 0.1857 | 29.88 | -24.85 | 14.81 | -43.92 | 2.31 | 18.44 | 6.00 |
| Beijing Konruns Pharmaceutical Co Ltd | 954.14m | 166.44m | 4.43bn | 447.00 | 26.15 | 1.40 | -- | 4.65 | 1.06 | 1.06 | 6.05 | 19.78 | 0.2548 | 2.50 | 3.73 | 2,134,547.00 | 5.46 | 5.43 | 6.39 | 6.24 | 88.29 | 89.93 | 21.44 | 20.76 | 3.08 | -- | 0.0486 | 21.53 | 6.15 | -2.08 | 48.24 | -10.63 | 43.05 | -9.71 |
| Shanghai Haixin Group Co Ltd | 1.11bn | 171.70m | 4.52bn | 760.00 | 36.64 | 1.59 | -- | 4.08 | 0.1422 | 0.1422 | 0.9185 | 3.27 | 0.2246 | 7.19 | 9.32 | 1,458,849.00 | 4.05 | 2.68 | 4.57 | 3.06 | 46.37 | 44.55 | 18.02 | 11.17 | 2.83 | -- | 0.0089 | 36.10 | -17.88 | 1.48 | 1.20 | 4.19 | -10.27 | 13.18 |
| Jiangsu Jibeier Pharmaceutical Co Ltd | 889.82m | 233.59m | 4.60bn | 1.45k | 19.55 | 2.35 | -- | 5.17 | 1.24 | 1.24 | 4.74 | 10.37 | 0.426 | 3.13 | 5.33 | 615,794.80 | 11.17 | 9.77 | 12.06 | 10.66 | 87.87 | 88.44 | 26.22 | 23.29 | 6.76 | -- | 0.005 | 30.68 | 31.49 | 12.16 | 41.65 | 17.79 | 112.78 | -- |
| Shanghai Hile Bio-Technology Co Ltd | 239.79m | 44.92m | 4.66bn | 295.00 | 105.83 | 3.73 | -- | 19.42 | 0.0669 | 0.0669 | 0.3664 | 1.90 | 0.154 | 1.06 | 2.40 | 812,857.50 | 2.06 | 1.73 | 2.56 | 2.47 | 45.19 | 50.44 | 13.37 | 10.37 | 1.16 | -- | 0.0562 | 23.89 | -19.76 | -1.11 | -48.30 | 24.17 | -41.32 | 23.47 |
| GemPharmatech Co Ltd | 638.97m | 157.34m | 4.68bn | 1.51k | 29.73 | 2.20 | -- | 7.32 | 0.3838 | 0.3838 | 1.56 | 5.20 | 0.2617 | 4.11 | 2.36 | 424,282.40 | 6.44 | 9.45 | 7.28 | 11.13 | 66.43 | 70.21 | 24.62 | 28.16 | 4.68 | -- | 0.0592 | 14.68 | 20.45 | 63.48 | -3.48 | -- | 141.38 | -- |
Data as of Jun 07 2024. Currency figures normalised to Shanghai Haixin Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
0.82%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Gfund Management Co., Ltd.as of 31 Dec 2023 | 4.06m | 0.55% |
| The Vanguard Group, Inc.as of 30 Apr 2024 | 842.45k | 0.11% |
| China Asset Management Co., Ltd.as of 31 Dec 2023 | 641.80k | 0.09% |
| Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 31 Dec 2023 | 167.10k | 0.02% |
| Western Leadbank Fund Management Co., Ltdas of 31 Dec 2023 | 143.30k | 0.02% |
| Hongde Fund Management Co., Ltd.as of 31 Dec 2023 | 103.10k | 0.01% |
| Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 36.80k | 0.01% |
| Morgan Stanley Huaxin Fund Management Co., Ltd.as of 31 Dec 2023 | 31.80k | 0.00% |
| E Fund Management Co., Ltd.as of 31 Dec 2023 | 8.50k | 0.00% |
| Harvest Fund Management Co., Ltd.as of 31 Dec 2023 | 6.40k | 0.00% |
More ▼
Data from 31 Dec 2023 - 29 Apr 2024Source: FactSet Research Systems Inc.
